Generic Name and Formulations:
Erythromycin 3%, benzoyl peroxide 5%; gel.
Cutanea Life Sciences, Inc.
Indications for AKTIPAK:
Contents must be mixed (in the palm of the hand) prior to use. Apply to cleansed, dried areas twice daily.
Avoid eyes, mouth, mucous membranes. Discontinue if excessive irritation occurs. Avoid excessive or prolonged exposure to sunlight. Flammable. Pregnancy (Cat.C). Nursing mothers.
Additive irritation with peeling, desquamating, abrasive agents. Concomitant other topical acne products: not recommended.
Macrolide antibiotic + antibacterial/ keratolytic.
Dry skin, application site reactions (eg, stinging, erythema, burning), blepharitis, pruritus, photosensitivity, peeling, superinfection; may bleach hair or fabrics.
Gel (dual-chamber pouches, mixed by patient)—60
Clinical Pain Advisor Articles
- Brain Plasticity in Patients With Complex Regional Pain Syndrome
- Chronic Pain Associated With Traumatic Brain Injury: Causes and Management
- Perturbation-Based Rehabilitation Effective for Chronic Low Back Pain
- Migraine Frequency Correlated With Depression and Anxiety
- IBS-Associated Chronic Pain: Formulation of Core Diagnostic Criteria
- Cannabis Use Associated With Aberrant Drug Behaviors
- Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse
- Independent Pharmacies Expanding Services Available to Patients
- Ketamine Exhibits Effective Pain Relief for Refractory Headaches
- Pain In Elite Athletes: IOC Recommendations on Contributing Factors and Treatment Approach
- Naproxen Plus Muscle Relaxants vs Naproxen Monotherapy for Low Back Pain
- Pain Processing: Examining the Role of Oxytocin
- Short- vs Long-Acting Opioids for Osteoarthritis Pain
- Extended-Release Naltrexone Injections Reduce Opioid Dependence
- Depressive Symptoms in Medical Interns Increased With Work-Family Conflicts